Literature DB >> 2690633

Estrogen replacement therapy: an overview.

D R Mishell1.   

Abstract

Levels of circulating estrogen fall during the perimenopausal period, resulting in changes in the postmenopausal woman's genitourinary tract, central nervous and cardiovascular systems, skin, and bone. Exogenous estrogen minimizes the benign symptoms and prevents the increased incidence of osteoporosis and atherosclerotic heart disease that accompany estrogen deficiency. Thus to avoid the recognized problems of estrogen deficiency, nearly all women should begin a lifelong course of estrogen replacement therapy during the perimenopausal period.

Entities:  

Mesh:

Year:  1989        PMID: 2690633     DOI: 10.1016/s0002-9378(89)80001-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Should clofibrate still be prescribed?

Authors:  M G Dunnigan
Journal:  BMJ       Date:  1992-08-15

2.  Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States).

Authors:  P K Green; N S Weiss; B McKnight; L F Voigt; S A Beresford
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.